Abstract:Abstract Background Alzheimer’s disease (AD) is a complex pathophysiological disease. Its progression is heterogenous and associated with clinical symptoms as well as prognosis. Hence, understanding the progression of AD is important in guiding patient management, evaluating treatment response and designing therapeutic trials. We developed and validated a novel machine learning model for revealing the underlying disease progression patterns from longitudinal multi-modal data of AD. Methods The prospective ADNI study data (1192 patients with cognitive impairment and 388 healthy controls) was used to train, validate and test a novel personalized hidden Markov model to identify disease-related states. The transition diagram of disease-related states exhibited two distinct disease progression patterns. We used the index of disease-related states as a predictor, and evaluated the prediction performance on time to conversion to AD dementia. External validation was performed on the AIBL cohort (87 patients with cognitive impairment and 179 healthy controls). Findings Our model identified ten biologically and clinically meaningful disease-related states from longitudinal multi-modal data, which constitute three non-overlapping stages (i.e., neocortical atrophy [NCA], medial temporal atrophy [MTA], and whole brain atrophy [WBA]) and two distinct disease progression patterns (i.e., NCA→WBA and MTA→WBA) hidden in the trajectories of AD patients. Disclosed patterns showed different atrophy trends of brain regions, and presented distinct genetic, clinical and biomarker characteristics, especially in the early course of the disease. The index of the identified disease-related states provided a remarkable performance on predicting the time to conversion to AD dementia (C-Index: 0.923±0.007), in comparison with the other commonly recognized AD risk factors, including APOE (0.607±0.012), MMSE score (0.808±0.006), Abeta (0.7445±0.013), pTau (0.689±0.006), and hippocampal volume (0.774±0.010). Interpretation A machine learning algorithm was proposed to capture the full spectrum of AD progression by identifying meaningful AD-related states as well as distinct disease progression patterns from longitudinal multi-modal data, showing its potential for promoting the understanding of heterogeneous disease progression, and early predicting the conversion time to AD dementia.

Towards Alzheimer's Disease Progression Assessment: A Review of Machine Learning Methods

Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review

Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data

Alzheimers Disease Diagnosis using Machine Learning: A Review

Machine learning in Alzheimer's disease drug discovery and target identification

Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis

Application Of Machine Learning Based On Genetic Data In The Study Of Alzheimer'S Disease

Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models

Deep Learning for Alzheimer's Disease Prediction: A Comprehensive Review

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

Addressing the Gaps in Early Dementia Detection: A Path Towards Enhanced Diagnostic Models through Machine Learning

Conventional machine learning and deep learning in Alzheimer's disease diagnosis using neuroimaging: A review

Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer's disease progression

A systematic literature review of machine learning approaches for class-wise recognition of Alzheimer's disease using neuroimaging-based brain disorder analysis

Automatic Detection of Alzheimer's Disease using Deep Learning Models and Neuro-Imaging: Current Trends and Future Perspectives

Prediction of Alzheimer's Disease Progression Based on Magnetic Resonance Imaging

A Review of Artificial Intelligence Technologies for Early Prediction of Alzheimer's Disease

Comprehensive overview of Alzheimer's disease utilizing Machine Learning approaches

Learning the progression and clinical subtypes of Alzheimer's disease from longitudinal clinical data

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

Application of Machine Learning to Predict the Risk of Alzheimer's Disease: An Accurate and Practical Solution for Early Diagnostics